Sign in

Sayna Norouzi, MD

@saynanorouzi.bsky.social
737 followers 65 following 66 posts

Academic Nephrologist|Director @GlomCon fellowship|Director👩🏼‍⚕️Glomerular Disease & PKD Clinics👠📟

PostsRepliesMedia
Reposted by Sayna Norouzi, MD
American Journal of Kidney Diseases @ajkd.bsky.social · 23/07/2026
#KDOQI US Commentary on the @kdigo.org 2024 Clinical Practice Guideline for the Management of Lupus Nephritis bit.ly/KDOQI26Lupus (FREE) @saynanorouzi.bsky.social @nkf-professionals.bsky.social
033
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 15/07/2026
Obesity in CKD: Treatment algorithm ca. 2026 from @ndt-era.bsky.social @saynanorouzi.bsky.social @rahaai.bsky.social #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/42446420/
082
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 29/05/2026
C3 glomerulopathy in transplant “like yet unlike native”: Pathophysiology, recent advances in therapeutics and evolving paradigms ca. 2026 @saynanorouzi.bsky.social #Nephpearls #NephSky 👉 www.wjgnet.com/2220-3230/fu...
041
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 12/06/2026
C3 glomerulopathy in transplant “like yet unlike native”: Pathophysiology, recent advances in therapeutics and evolving paradigms ca. 2026 @saynanorouzi.bsky.social #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/42281853/
021
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 23/06/2026
Fabry Disease: Current Perspectives on Diagnosis and Management Strategies ca. 2026 from @akdhjournal.bsky.social @saynanorouzi.bsky.social #Nephpearls #NephSky 👉🏼 pubmed.ncbi.nlm.nih.gov/42331443/
022
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 22/05/2026
Glomerular frontiers: consensus perspectives from @glomcon.org @n0r0zha.bsky.social @poyanmehr.org @bettercallseeth.bsky.social @saynanorouzi.bsky.social #GlomconHawaii 🌊 2025 #NephSky #Nephpearls 👉 link.springer.com/article/10.1...
043
Reposted by Sayna Norouzi, MD
NephMadness @nephmadness.bsky.social · 28/04/2026
Thank you to the #NephMadness commentary writers: Abhilash Koratala Autumn Harris Jonathan Barratt @anujajava.bsky.social Donald Molony Farhana Begum Mirtha Camila Almanzar Jordan G. Nestor @saynanorouzi.bsky.social Saloni Gupta Song Ong Dana Rizk Catch up here: bit.ly/NM26Comms
131
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 29/03/2026
Trying to catch up with #IgAN trials⁉️ Check out 👉 “IgAN: An Overview of the Clinical Trials” ca. 2025 from @kidneymed.bsky.social @haresh11.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social #ISNWCN 🇯🇵 #WCN26 🇯🇵 #WCN2026 🇯🇵 #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/41050133/
021
Reposted by Sayna Norouzi, MD
NephMadness @nephmadness.bsky.social · 08/04/2026
Learn more about C3G Treatment in this #NephMadness commentary by @saynanorouzi.bsky.social and Saloni Gupta on the #AJKDBlog: C3G Treatment–The Ultimate Glow-Up Story bit.ly/NM26NorouziG...
bit.ly
#NephMadness 2026: C3G Treatment–The Ultimate Glow-Up Story
Sayna Norouzi @SaynaNorouzi – @saynanorouzi.bsky.social Sayna Norouzi is an associate professor of Medicine and clinical nephrologist at Loma Linda University Medical Center and completed her…
122
Reposted by Sayna Norouzi, MD
American Journal of Kidney Diseases @ajkd.bsky.social · 09/04/2026
Learn more about C3G Treatment in this #NephMadness commentary by @saynanorouzi.bsky.social and Saloni Gupta on the #AJKDBlog: C3G Treatment–The Ultimate Glow-Up Story bit.ly/NM26NorouziG...
bit.ly
#NephMadness 2026: C3G Treatment–The Ultimate Glow-Up Story
Sayna Norouzi @SaynaNorouzi – @saynanorouzi.bsky.social Sayna Norouzi is an associate professor of Medicine and clinical nephrologist at Loma Linda University Medical Center and completed her…
111
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 27/02/2026
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies ca. 2026 from @kidneymed.bsky.social @jzrenalpath.bsky.social @drraymondhsu.bsky.social @saynanorouzi.bsky.social #Nephpearls 👉 www.sciencedirect.com/science/arti...
0104
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 02/03/2026
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies ca. 2026 from @kidneymed.bsky.social @saynanorouzi.bsky.social 📢 This paper is a very timely read for #NephMadness #Nephpearls #NephSky 👉🆓 www.sciencedirect.com/science/arti... 👉 ajkdblog.org/2026/03/01/n...
082
Reposted by Sayna Norouzi, MD
American Journal of Kidney Diseases @ajkd.bsky.social · 13/01/2026
IgG3κ Monoclonal Membranous Nephropathy Associated With Acquired Lecithin Cholesterol Acyltransferase Deficiency bit.ly/3Le1OFK
033
Sayna Norouzi, MD @saynanorouzi.bsky.social · 11/01/2026
Genetic testing is transforming how we practice nephrology. Check out our recent article in KidneyNews. #Nephrology #Genetics #KidneyDisease
042
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 09/01/2026
Check out 👉🏼 From Variant to Bedside, Making Genetics 🧬 Routine in #Nephrology #Nephpearls #NephSky @saynanorouzi.bsky.social This is our choice for ⚡️Kidney Watch⚡️ 2026 published in the January 2026 issue of @asnpublications.bsky.social 👉 www.kidneynews.org/view/journal...
051
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 18/12/2025
Obesity‑related glomerulopathy, A growing kidney burden in the obesity pandemic ca. 2025 from @jzrenalpath.bsky.social @saynanorouzi.bsky.social #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/41410808/
0117
Reposted by Sayna Norouzi, MD
Alex Chang, MD @alexchangmd.bsky.social · 07/12/2025
Excellent Rare Kidney Disease Conference hosted by Loma Linda at the historic Mission Inn led by @saynanorouzi.bsky.social great case discussions on IgA nephropathy, c3G, PKd, genetic testing and galore! Enjoyed the AI discussant as an additional panelist, and Dr Glassock taking down AI bots
182
Sayna Norouzi, MD @saynanorouzi.bsky.social · 29/11/2025
Exploring the Role of Plant-Based Nutrition in Polycystic Kidney Disease pubmed.ncbi.nlm.nih.gov/41305569/
pubmed.ncbi.nlm.nih.gov
Exploring the Role of Plant-Based Nutrition in Polycystic Kidney Disease - PubMed
Polycystic kidney disease (PKD) is a genetic disorder characterized by progressive kidney cyst formation and eventual kidney failure. Emerging evidence suggests that plant-based diets may confer therapeutic benefits in patients with PKD by modulating mTOR and AMPK signaling, reducing oxidative stres …
161
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 07/11/2025
Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social #Nephpearls #KidneyWk #NephSky 👉 www.kireports.org/article/S246...
053
Reposted by Sayna Norouzi, MD
Izabela Zakrocka @izabelazakrocka.bsky.social · 07/11/2025
Great start of ‚Hot topics in lupus nephritis’ session chaired by @saynanorouzi.bsky.social and Juan M. Mejia-Vilet, with an excellent lecture of @kronbichlerlab.bsky.social on 25’ treatment targets #KidneyWk @asnkidney.bsky.social
154
Sayna Norouzi, MD @saynanorouzi.bsky.social · 30/10/2025
🔥 Brilliant session by the legendary Dr. Glassock at the #GlomCon Fellowship! Limiting #LupusNephritis flares is JUST as important as treatment. ✅ Prevent relapses → ↓ risk of #ESKD 🎯 Goal: Immunological remission (normal complements, neg. anti-dsDNA) @glomcon.org
020
Sayna Norouzi, MD @saynanorouzi.bsky.social · 30/10/2025
📟Do female nephrologists feel as supported as their male colleagues? Do they face the same challenges? For the first time, our study compares the perspectives of female and male nephrologists; exploring differences in perceived support and professional obstacles. @asnkidney.bsky.social
001
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 18/10/2025
Empowering the Next Generation of Nephrologists: Trainee Opportunities in #GlomCon Ecosystem from @asnpublications.bsky.social @glomcon.org @bettercallseeth.bsky.social @saynanorouzi.bsky.social @nephrologista.bsky.social @poyanmehr.org #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/41105470/
0136
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 06/10/2025
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social #Nephpearls #NephSky 👉 pubmed.ncbi.nlm.nih.gov/41050133/
034
Sayna Norouzi, MD @saynanorouzi.bsky.social · 29/09/2025
Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟 We deeply appreciate and value your partnership. Hope to see you all next year, in Maui August 3-7 ⭐️ Mahalo!! 🌺 @glomcon.org
021
Sayna Norouzi, MD @saynanorouzi.bsky.social · 29/09/2025
Huge thank you to our incredible faculty, attendees, sponsors, and GlomCon instructors for making #GlomConHawaii conference a success! 🌟 We deeply appreciate and value your partnership. Hope to see you all next year, in Maui August 3-7 ⭐️ Mahalo!! 🌺
010
Sayna Norouzi, MD @saynanorouzi.bsky.social · 24/09/2025
What a fantastic evening at the #GlomConHawaii reception! Thank you to everyone who joined us🥰 It’s a privilege to be part of such an exceptional community. The future of nephrology is bright. @glomcon.org
093
Reposted by Sayna Norouzi, MD
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 24/09/2025
Excellent thread below I will also plug this talk by Paola Romagnani on podocytopathies youtu.be/bRMeqaGgA9I?... #GlomCon #NephGR
youtu.be
Personalized Therapy for Podocytopathies with Prof. Paola Romagnani
YouTube video by Ottawa Nephrology
0115
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 15/05/2025
Register here 👉 glomconhawaii.org #GlomConHawaii2025 #GlomConHawaii #GlomCon
glomconhawaii.org
Home | GlomCon Hawaii
GlomCon Hawaii is an annual in-person and hybrid conference dedicated to advancing education, research, and collaboration in nephrology. As part of GlomCon Foundation's initiative, the conference brin...
042
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 25/02/2025
This year’s in-person gathering promises to strengthen connections, spark deeper collaboration, and elevate the learning experience in beautiful Hawaii. Can't join us in person? We plan to live-stream the main sessions; see you on the virtual side. #GlomConHawaii #GlomCon
bit.ly
glomcon Event
Enjoy the event with us!
021
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 22/09/2025
Clinical Endpoints for Glomerular Diseases from @hjanders.bsky.social #GlomConHawaii 🌊 #Nephpearls #NephSky
072
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 07/08/2025
IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @saynanorouzi.bsky.social #Nephpearls #NephSky www.kidneymedicinejournal.org/article/S259...
kidneymedicinejournal.org
IgA Nephropathy: An Overview of the Clinical Trials
IgA nephropathy (IgAN) is characterized by the deposition of poorly-O-galactosylated IgA1 (also referred to as galactose-deficient IgA1 or gd-IgA1) containing immune complexes in the glomerular mesang...
081
Reposted by Sayna Norouzi, MD
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 02/07/2025
Congrats @sophia-kidney.bsky.social @saynanorouzi.bsky.social @kashvilunawat.bsky.social And all the other awardees of the @asnkidney.bsky.social NephCure grants! www.kidneycure.org/pages/qa.aspx
kidneycure.org
KidneyCure | Spotlights/Q&A - Who We Fund
Learn more about who KidneyCure funds.
2135
Reposted by Sayna Norouzi, MD
Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 21/06/2025
It’s not just the immune mediated and infections - we need to pay attention to cardiovascular disease in SLE pubmed.ncbi.nlm.nih.gov/40539000/ Nice job synthesizing the data @saynanorouzi.bsky.social and team! #NephSky #lupuschat
pubmed.ncbi.nlm.nih.gov
Cardiovascular Events in Lupus Nephritis: A Systematic Review and Meta-Analysis - PubMed
CVE occurrence among individuals with LN is significant, and this disease entity increases CVE risk, highlighting the importance of implementing early therapeutic interventions to prevent poor outcome...
12010
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 06/06/2025
#GlomConHawaii 2025 🌴🌊 session: Post-market Evaluations, Registries, and RWE Studies Register here 👉 glomconhawaii.org #GlomConHawaii2025 #GlomConHawaii #GlomCon
121
Reposted by Sayna Norouzi, MD
Izabela Zakrocka @izabelazakrocka.bsky.social · 05/06/2025
@saynanorouzi.bsky.social rocks in Vienna #ERA25! @glomcon.org
274
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 05/05/2025
🚨 Exciting News! 🚨 The GlomCon Foundation, American Kidney Fund, and IgA Nephropathy Foundation have joined forces to develop the consensus framework for establishing Centers of Excellence in Glomerular Disease Care! 🔗 Learn more: www.glomcon.org/news-release...
132
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 01/05/2025
Applications are now open for the Polycystic Kidney Disease Medical Directorship Program (PKD-MDP)! 🤩 🔗 Apply here: www.glomcon.org/pkdmd-program 📅 Deadline to apply is July 15, 2025
134
Reposted by Sayna Norouzi, MD
HCPLive @hcplivenews.bsky.social · 26/04/2025
Q1 was full of important advances in #nephrology, especially in glomerular diseases. Hear from @SaynaNorouzi @LLUHealth @GlomCon as she reflects on some of these developments and looks ahead to what might be in store for the rest of 2025: www.hcplive.com/view...
hcplive.com
What’s New and What’s Next in Glomerular Disease Care, with Sayna Norouzi, MD
Norouzi reflects on significant advances in glomerular disease from Q1 and looks ahead to what the rest of 2025 may have to offer.
011
Reposted by Sayna Norouzi, MD
Sayna Norouzi, MD @saynanorouzi.bsky.social · 26/02/2025
Are you effectively preventing VTE in your patients with nephrotic syndrome? Check out our paper below on KI reports about this important topic. It's a fantastic collaboration with some truly brilliant minds! #NephSky @glomcon.org www.kireports.org/article/S246...
kireports.org
Venous thromboembolism prevention for nephrotic syndrome: The role of aspirin, vitamin K antagonists and direct oral anticoagulants
Nephrotic syndrome (NS) carries a significantly elevated risk of venous thromboembolic events (VTE), contributing to morbidity and mortality. Current guidelines for VTE prophylaxis in NS are based on ...
11610
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 16/04/2025
GlomCon is thrilled to introduce a new leadership training opportunity 🤩 The Polycystic Kidney Disease Medical Directorship Program (PKD-MDP) is a year-long, interactive program aiming to deepen participants' expertise in PKD diagnosis and management. Applications open May 1.
121
Sayna Norouzi, MD @saynanorouzi.bsky.social · 08/04/2025
Smoking-modified HTN-associated nodular glomerulosclerosis (SHaNGS), a form of hypertensive glomerulosclerosis in the context of alteration by smoking products. pmc.ncbi.nlm.nih.gov/articles/PMC11…
000
Reposted by Sayna Norouzi, MD
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 03/04/2025
Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social @kdjhaveri.bsky.social #Nephpearls #NephSky 👉 www.kireports.org/article/S246...
383
Sayna Norouzi, MD @saynanorouzi.bsky.social · 04/04/2025
In August 2024, GlomCon launched its 1st international hybrid conference on GN in Maui. Diverse group of expert faculty of 52 members, achieving an intentional and balanced gender representation of 50% male and 50% female. The event reached a total of 619 registrations. karger.com/gdz/article/5/…
karger.com
000
Sayna Norouzi, MD @saynanorouzi.bsky.social · 04/04/2025
The FDA approved inebilizumab-cdon (UPLIZNA; @Amgen as the first and only treatment for adult patients diagnosed with immunoglobulin G4-related disease (IgG4-RD). #RareDiseases pubmed.ncbi.nlm.nih.gov/39969992/
pubmed.ncbi.nlm.nih.gov
IgG4-Related Kidney Disease - PubMed
IgG4-Related Kidney Disease
042
Sayna Norouzi, MD @saynanorouzi.bsky.social · 28/03/2025
Thank you, @khon2news.bsky.social News for inviting us this morning to discuss Rare Kidney Disease and the @nkf-professionals.bsky.social (Hawaii). ⭐️ Join us for the NKF Hawaii Kidney walk on Saturday🤍#PatientAdvocacy #RareKidneyDiseases kidneywalk.org/hawaii
130
Reposted by Sayna Norouzi, MD
glomcon.org @glomcon.org · 11/03/2025
𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀! GlomCon has convened an international expert panel to develop criteria for Centers of Excellence—and we’ll share the findings at #GlomConHawaii2025. Stay tuned for more updates on our new clinics and workshop! #GlomCon
042
Reposted by Sayna Norouzi, MD
National Kidney Foundation @kidney.org · 11/03/2025
Your generosity during #NationalKidneyMonth will be matched dollar-for-dollar, up to $50,000. That means your gift will have twice the power to change lives and bring hope to those affected by kidney disease. Make an impacthttps://buff.ly/41htQVh
041
Reposted by Sayna Norouzi, MD
Nephrology Journal Club @nephjc.bsky.social · 12/03/2025
T3d: Here are the trials with cell B blockers (yeah, induction, refractory LN, or whatever). Any notable differences in their design? #nephjc
21310